CENTEK(000931)
Search documents
中关村:下属公司盐酸曲马多片通过一致性评价
Xin Lang Cai Jing· 2026-02-09 08:00
Core Viewpoint - Beijing Huasu Pharmaceutical, a subsidiary of Zhongguancun, has received notification from the National Medical Products Administration that its product "Tramadol Hydrochloride Tablets" (50mg) has passed the consistency evaluation for generic drug quality and efficacy [1] Group 1: Company Developments - Beijing Huasu is the fourth company to pass the consistency evaluation, joining three other companies that have already received approval [1] - The project has incurred a total research and development cost of approximately 5.9 million yuan [1] Group 2: Market Impact - The successful evaluation is expected to enhance the competitiveness of the drug and positively impact the company's performance [1] - However, drug sales are influenced by various factors, leading to inherent uncertainties [1]
中 关 村(000931) - 关于下属公司北京华素盐酸曲马多片通过一致性评价的公告
2026-02-09 08:00
关于下属公司北京华素盐酸曲马多片通过一致性评价的公告 共 3 页 证券代码:000931 证券简称:中关村 公告编号:2026-017 北京中关村科技发展(控股)股份有限公司 关于下属公司北京华素盐酸曲马多片通过一致性评价的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 北京中关村科技发展(控股)股份有限公司(以下简称:公司)于 2025 年 1 月披露《关于下属公司北京华素盐酸曲马多片一致性评价申报收到国家药品 监督管理局<受理通知书>的公告》(公告编号:2025-006)。 近日,公司下属公司北京华素制药股份有限公司(以下简称:北京华素) 收到国家药品监督管理局核准签发的《药品补充申请批准通知书》(通知书编 号:2026B00624),获悉,北京华素生产的"盐酸曲马多片"(规格:50mg) 通过了仿制药质量和疗效一致性评价,具体情况如下: 一、批件主要内容 通知书编号:2026B00624 药品名称:盐酸曲马多片 剂型:片剂 规格:50mg 注册分类:化学药品 受理号:CYHB2550038 上市许可持有人、生产企业:北京华素制药股份有限公司 包装规 ...
中关村数字经济总部园主体结构全面封顶
Xin Lang Cai Jing· 2026-02-08 18:30
Core Viewpoint - The construction of the Zhongguancun Digital Economy Headquarters Park is progressing well, with the main structure completed ahead of schedule, showcasing innovative construction techniques and strong team commitment [1][3]. Group 1: Project Overview - The total construction area of the Zhongguancun Digital Economy Headquarters Park is 407,900 square meters, making it the largest ongoing TOD industrial park in Haidian [1]. - The project is located near the Qinghe transportation hub and is expected to be completed by May 2027, integrating industrial offices, vibrant commercial spaces, high-end hotels, and serviced apartments [3]. Group 2: Construction Challenges and Solutions - The project faced significant challenges, including uneven groundwater levels and complex geological conditions, which were addressed through innovative dewatering methods [1]. - A combination of "vacuum pump lightweight well points + drainage wells" was successfully implemented to tackle the underground water issues, facilitating subsequent construction [1]. Group 3: Technological Innovations - A 350-meter long prefabricated steel bridge was constructed to enhance transportation efficiency, increasing horizontal transport capacity by 40% and concrete pouring volume by 85% [2]. - The use of intelligent construction robots has significantly improved efficiency, with construction speed increased by 2-3 times compared to manual labor [2]. Group 4: Team Commitment - The construction team demonstrated strong dedication, with many workers postponing their return home for the New Year to meet project deadlines, reflecting their sense of responsibility [3]. - At peak construction, over 2,000 workers were on-site, with a commitment to continue working through the holiday period to ensure project completion [3].
中关村数字经济总部园主体结构封顶
Xin Lang Cai Jing· 2026-02-08 17:26
本报讯 (记者 边磊) 近日,毗邻清河交通枢纽的中关村数字经济总部园主体结构全面封顶。这座总建 筑面积达40.79万平方米的海淀最大在施TOD产业园区,仅用3个月就实现从"正负零"到高楼林立的跨 越,彰显了北京建工六建的铁军风采,更为中关村数字经济发展注入新动能。 (来源:劳动午报) 转自:劳动午报 据了解,作为承载区域数字经济发展愿景的重点项目,中关村数字经济总部园预计2027年5月完工,将 打造集产业办公、活力商业、高端酒店、服务式公寓于一体的TOD创新产城融合体。未来,该项目将 强化与小米科技园、上地信息产业基地等创新载体的协同,聚焦人工智能、大信息、大健康等核心产 业,聚集行业领军企业,助力海淀打造数字经济引领区和人工智能创新策源地。 本报记者 于佳 摄 ...
股市直播|杉杉股份:控股股东及其子公司签署重整投资协议;萃华珠宝:公司主要银行账户被冻结股票交易10日起被实施其他风险警示
Shang Hai Zheng Quan Bao· 2026-02-08 13:40
Performance Highlights - Guomachine General reported a net profit of 585.16 million yuan for 2025, a year-on-year increase of 45.71% with total revenue of 899 million yuan, up 17.32% [5] - Tianshili achieved a net profit of 1.105 billion yuan, a 15.68% increase year-on-year, despite a revenue decline of 3.08% to 8.236 billion yuan [5] - Focus Technology's net profit rose by 11.73% to 504 million yuan, with total revenue reaching 1.92 billion yuan, up 15.06% [5] - Times Electric reported a net profit of 4.105 billion yuan, a 10.88% increase, with total revenue of 28.761 billion yuan, up 15.46% [5] - Tongxingbao's net profit increased by 5.51% to 221 million yuan, with total revenue of 1.068 billion yuan, up 19.24% [5] Capital Increase & Restructuring - Ruili Kemi is planning to issue shares to acquire a 16% stake in its subsidiary, with trading suspended from February 9 [6] - Longyun Co. intends to acquire a 58% stake in Yuheng Film and Television, with trading resuming on February 9 [6] - Yingwang Yingchuang is set to acquire 100% of Lianshi Legend, a smart marketing service provider [6] - Jiantou Energy's application for a specific stock issuance has been approved by the Shenzhen Stock Exchange [6] - Shanshan Co. signed a restructuring investment agreement with its controlling shareholder [6] Major Events - Aihuilong received a notice of investigation from the China Securities Regulatory Commission for suspected information disclosure violations [9] - Tiansheng New Materials also received a notice of investigation for similar reasons [10] - Cloud Road Co. announced the lifting of the detention of its chairman and general manager [10] - TCL Zhonghuan's subsidiary signed a patent licensing agreement with Aiyu Co. for a total fee of 1.65 billion yuan [11] - Shenjian Co. reported that its aerospace business revenue is relatively small, accounting for less than 1% of total revenue [11] Investment Projects - Wantong Expressway plans to invest approximately 5.42 billion yuan in the renovation and expansion of the Lianhuo Expressway [15] - Zhixin Co. intends to invest up to 1.1 billion yuan in an automotive welding parts project [15] - Hangyu Technology plans to invest up to 1.05 million euros in a forging production base in Slovakia [15] - Dongtianwei is set to invest 400 million yuan in a global R&D center and manufacturing headquarters in South China [15] - Zhongguancun is planning to build a modern digital factory for traditional Chinese medicine in Jiamusi City [15] Stock Trading Updates - The stock of Cuihua Jewelry will be suspended for one day starting February 9 due to the freezing of its main bank accounts [4] - The stock of Longyun Co. will resume trading on February 9 after a suspension [23] - Ruili Kemi and Yongtai Technology will be suspended from trading starting February 9 [24]
科技人才领军,多项全球首创医工交叉硬科技亮相中关村
Bei Jing Ri Bao Ke Hu Duan· 2026-02-08 10:42
胃镜筛查是一项对不少人来说不可或缺的医学检查手段,但现有筛查手段存在明显局限:胃镜侵入式且 需麻醉,无线磁控胶囊内镜图像差、盲区多,还存在滞留风险。北京大学第一医院内镜中心主任戎龙带 来的超微型磁控内窥镜系统,采用全球首创"有线传输+磁控"双模驱动技术,可实现上消化道无痛、高 清、实时、可控的全流程筛查,为上消化道疾病早筛早治大规模普及提供了创新解决方案。 2月7日,奇点创智·人才系列交流活动之医工交叉专场活动在集智未来人工智能产业创新基地举行,全 球首创CT/MRI 孔径内实时可视化微创机器人系统、全球首款无创全脑多通道脑氧监护仪、全球最细超 微型磁控内窥镜系统……一批来自北京知名高校、医院和科技企业的医工交叉前沿科技成果在活动上路 演亮相。 来源:北京日报客户端 北京医院肿瘤微创治疗中心主任李晓光带来的全球首创CT/MRI 孔径内实时可视化微创机器人系统,中 科搏锐公司的全球首款无创全脑多通道脑氧监护仪,北京积水潭医院主任医师周一新团队的"膝关节重 建个性化假体外形调制与植入关键技术"……涵盖仿生神经导管、无创脑机接口、无创全脑多通道脑氧 监护仪等多个前沿赛道的医工交叉领域创新成果接连亮相,每一项成果都紧 ...
中关村AI北纬社区启动“一人公司”加速营
Xin Lang Cai Jing· 2026-02-07 21:54
Core Insights - The article discusses the launch of the "Token Camp Artificial Intelligence OPC Acceleration Program" by the Zhongguancun AI Beiwai Community, aimed at building a global top-tier AI ecosystem focused on "one-person companies" [1][2] - The program targets early-stage AI innovation teams and university research commercialization teams, providing a comprehensive support platform over a one-month period with six offline courses [1] - The initiative emphasizes the importance of computing power as a foundational element for AI innovation and introduces the "OPC Computing Power Support Plan" to address the computing challenges faced by early teams [1] Group 1 - The "Token Camp" program aims to empower "one-person companies" by offering full-cycle support across four core dimensions: technology, industry, capital, and policy [1] - The program includes free access to general Token quotas, high-spec computing card usage rights, and comprehensive technical support services to help early teams validate and iterate at low costs [1] - A partnership agreement was signed between the Zhongguancun AI Beiwai Community and the China Academy of Information and Communications Technology to co-build a public service platform for AI [2] Group 2 - The Zhongguancun AI Beiwai Community plans to continuously offer a combination of "acceleration programs, computing power support, and ecological cooperation" to enhance the innovation environment [2] - The initiative aims to optimize the ecosystem for AI industry development and promote the prosperity of artificial intelligence [2]
助力“单人成军”,中关村AI北纬社区启动人工智能OPC加速营计划
Xin Lang Cai Jing· 2026-02-07 09:27
Core Insights - The article discusses the launch of the "Token Camp AI OPC Acceleration Program" aimed at fostering early-stage AI innovation through a specialized support platform [2] - The program focuses on "One-Person Companies" (OPC), which are seen as highly dynamic units of innovation, and aims to build a global AI innovation hub in Haidian District [4] Group 1: Program Overview - The OPC Acceleration Program will target two main groups: AI-native teams and university research commercialization teams, providing a comprehensive support system over one month with six offline courses [4] - The program will cover four core dimensions: technology, industry, capital, and policy, assisting OPC entrepreneurs in efficiently achieving innovation and overcoming development bottlenecks [4] Group 2: Computing Power Support - The "OPC Computing Power Support Plan" was launched to address the computing power challenges faced by early-stage teams, leveraging resources from authoritative organizations like the China Academy of Information and Communications Technology [6] - Key benefits include free general Token quotas, free access to high-spec computing cards, and comprehensive technical support to help teams validate and iterate at low costs [6] Group 3: Collaboration and Innovation - A partnership was established between the Zhongguancun AI North Latitude Community and the China Academy of Information and Communications Technology to create a public service platform for OPC AI [6] - The event featured presentations from OPC representatives showcasing advanced AI applications, such as automated script generation and full-stack development [6][11] Group 4: Cultural Impact - The release of the "OPC Song" specifically for OPC entrepreneurs reflects the community's commitment to supporting innovation, with lyrics that inspire and unite the entrepreneurial spirit [10] - The music video for the song was produced using AI technology from an OPC company, demonstrating the intersection of technology and creative arts [10]
中关村:关于与桦川县人民政府签订中药、原料药基地建设项目框架协议的公告
Zheng Quan Ri Bao· 2026-02-06 14:22
Core Viewpoint - The company has signed a framework agreement with the government of Huachuan County, Jiamusi City, Heilongjiang Province, to establish a modern digital factory for traditional Chinese medicine and raw pharmaceutical production, aligning with the national "big health" industry development strategy [2] Group 1 - The project aims to enhance production capacity in the traditional Chinese medicine and raw pharmaceutical industry [2] - The company plans to build a leading manufacturing base in the industry in Huachuan County, Heilongjiang Province [2] - Funding for the project will primarily come from the company's own resources [2]
2月6日晚间重要公告一览
Xi Niu Cai Jing· 2026-02-06 10:12
Group 1 - ZTE Corporation plans to invest 200 million RMB to subscribe to the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Guidance Fund, focusing on areas supported by national policies such as new generation information technology and biotechnology [1] - Huayi Jewelry's subsidiary has reported overdue loans totaling 200 million RMB due to tight liquidity, with a cumulative overdue principal of 254 million RMB [2] - Guangzhou Baiyunshan Pharmaceutical's subsidiary has received approval for the consistency evaluation of Alfacalcidol soft capsules, which are used to treat calcium metabolism disorders [3] Group 2 - Kunming Pharmaceutical Group reported a 21.72% decline in revenue to 6.577 billion RMB and a 46% drop in net profit to 350 million RMB for 2025 [4] - Jiantou Energy's application for a specific stock issuance has been approved by the Shenzhen Stock Exchange [5] - Jinchuan Titanium Industry's subsidiary has temporarily suspended its sulfuric acid production due to reduced demand [6] Group 3 - Kelun Pharmaceutical's subsidiary has received approval for a new indication for its antibody-drug conjugate, which is used to treat advanced hormone receptor-positive breast cancer [7] - Fawer Co., Ltd. has completed the relocation of its Chongqing Yuantai Shock Absorber Company and commenced production [8] - Jiuzhoutong's subsidiary has received acceptance for the listing application of Betahistine Hydrochloride tablets [9] Group 4 - Zhongguancun plans to build a traditional Chinese medicine and raw material drug production base in Jiamusi City, Heilongjiang Province [11] - China Wuyi announced that part of its land in Kenya has been requisitioned by the government, with compensation of approximately 6.25 million RMB [12] - Times Electric reported a 15.46% increase in revenue to 28.761 billion RMB and a 10.88% increase in net profit to 4.105 billion RMB for 2025 [13] Group 5 - Top Cloud Agriculture's shareholder has received regulatory measures from the Zhejiang Securities Regulatory Bureau for failing to timely disclose shareholding changes [14] - Xinwanda's subsidiary has reached a settlement in a lawsuit involving over 2.314 billion RMB, with an estimated impact of 500 to 800 million RMB on net profit for 2025 [15] - Dongrui Co., Ltd. reported a 25.19% increase in pig sales revenue in January, totaling 214 million RMB [16] Group 6 - Tianjin Tianshi reported a 3.08% decline in revenue to 8.236 billion RMB, while net profit increased by 15.68% to 1.105 billion RMB for 2025 [17] - Wantong Expressway plans to invest approximately 5.42 billion RMB in the renovation and expansion of the Lianhuo Expressway [18] - Qiaoyin Co., Ltd. has pre-qualified for a sanitation integration service project worth approximately 73.8 million RMB [20] Group 7 - Jindi Co., Ltd. plans to acquire 100% equity of Yuni Precision for 116 million RMB, focusing on precision stamping products [21] - Heng Rui Medicine's HRS-4642 injection has been included in the list of breakthrough therapeutic varieties [22] - Tongde Chemical has had some assets frozen due to a financing lease dispute [23] Group 8 - Zhongli Co., Ltd. is establishing an industrial fund with a total commitment of approximately 408.76 million RMB, focusing on new materials and artificial intelligence [24] - Tianbang Food reported a 9.93% increase in pig sales revenue in January, totaling 674 million RMB [25] - New Hope reported a 10.03% decrease in pig sales revenue in January, totaling 1.628 billion RMB [26] Group 9 - Tainkang's subsidiary has received a drug registration certificate for Minoxidil topical solution [27] - Lihua Co., Ltd. reported a 9.8% increase in chicken sales revenue in January, totaling 1.289 billion RMB [28] - Guojitong General reported a 45.71% increase in net profit to 58.52 million RMB for 2025 [29] Group 10 - Zhixin Co., Ltd. plans to invest up to 1.1 billion RMB in an automotive stamping and welding parts project [30] - Chuangyuan Technology's subsidiary has pre-qualified for a National Grid project worth approximately 94.77 million RMB [31] - Lisheng Pharmaceutical's adenine phosphate raw material has passed the listing application [32] Group 11 - Tongguang Cable's subsidiary has pre-qualified for a National Grid project worth approximately 108 million RMB [33] - Zhenghong Technology reported a 7.74% increase in pig sales revenue in January, totaling 14.35 million RMB [34] - Pengding Holdings reported a 0.07% decrease in consolidated revenue in January, totaling 2.701 billion RMB [35] Group 12 - Hongri Pharmaceutical has received approval for clinical trials of its injectable drug for acute pancreatitis [36][37] - Xinhua Medical has decided to terminate the acquisition of a 36.19% stake in Wuhan Zhongzhi Biotechnology [38] - Tianyu Bio reported an 11.23% decrease in pig sales revenue in January, totaling 54.29 million RMB [39]